+ Add Chrome Extension

CNN

News
28 days ago
2  Likes 0  Comments

About this Deal

New Phase 3 trial data finds a single shot of Regeneron's Covid-19 antibody cocktail was able to prevent symptomatic Covid-19 among people exposed to the virus, the company said Monday.

Regeneron said it will seek expansion of the emergency use authorization for the drug, which is currently available in the United States to treat mild-to-moderate Covid-19 in people already infected with the coronavirus.

Read the full article here

🏷 Deal Tags

News CNN Covid-19 CNN news vaccine
What's the matter?

💬 Comments

Thanks! Worked! 👍 🙏 🤩 💕 🥳 🔥 😍
👀 Related Deals